|
HS Code |
286325 |
| Chemical Formula | C30H16O9 |
| Molar Mass | 520.44 g/mol |
| Solubility In Water | Poor (due to non - polar and large organic structure) |
| Solubility In Organic Solvents | Soluble in some organic solvents like DMSO, DMF (aromatic and polar organic solvents) |
| Uv Vis Absorption | Absorbs in the visible and UV range due to conjugated π - systems (benzofuran and xanthene moieties) |
| Fluorescent Property | May exhibit fluorescence due to the rigid and conjugated structure |
| Stability | Stable under normal conditions but may decompose under high heat, strong acids or bases |
As an accredited 1-{[(3',6'-Dihydroxy-3-Oxo-3H-Spiro[2-Benzofuran-1,9'-Xanthen]-5-Yl)Carbonyl]Oxy}Pyrrolidine-2,5-Dione factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of 1-{[(3',6'-Dihydroxy - 3 - Oxo - 3H - Spiro[2 - Benzofuran - 1,9'-Xanthen]-5 - Yl)Carbonyl]Oxy}Pyrrolidine - 2,5 - Dione in sealed container. |
| Shipping | The chemical 1-{[(3',6'-Dihydroxy - 3 - Oxo - 3H - Spiro[2 - Benzofuran - 1,9'-Xanthen]-5 - Yl)Carbonyl]Oxy}Pyrrolidine - 2,5 - Dione is shipped in specialized, sealed containers. These ensure safe transit, protecting from external factors like moisture and light. |
| Storage | Store "1-{[(3',6'-Dihydroxy-3 - Oxo - 3H - Spiro[2 - Benzofuran - 1,9'-Xanthen]-5 - Yl)Carbonyl]Oxy}Pyrrolidine - 2,5 - Dione" in a cool, dry place, away from direct sunlight and heat sources. Keep it in a tightly - sealed container to prevent exposure to moisture and air, which could potentially lead to chemical degradation. Avoid storing near incompatible substances. |
NHS-Fluorescein Conjugate Migration Kinetics Across Nitrocellulose Pore ArchitecturesLateral flow immunochromatography membranes—specifically polyester-backed, surfactant-treated nitrocellulose matrices with nominal capillary flow times of 135–165 seconds per 4 cm—exhibit a non-linear sensitivity cliff when the fluorophore-to-antibody molar input ratio exceeds 12:1. This cliff manifests as an avalanche of test-line ghosting induced by unconjugated fluorescein species adsorbing indiscriminately to streptavidin-biotin capture zones. Process engineers operating reel-to-reel dispensers (such as the Kinematic Matrix 1600 with 3-zone drying) document that pre-treatment of anti-CRP monoclonal antibodies with 1-{[(3',6'-Dihydroxy-3-Oxo-3H-Spiro[2-Benzofuran-1,9'-Xanthen]-5-Yl)Carbonyl]Oxy}Pyrrolidine-2,5-Dione} at a molar ratio of 8:1, in 50 mM sodium borate buffer adjusted to pH 8.7 ± 0.1 at 293 K, minimizes this ghosting without sacrificing visual detection limit. The industry compliance framework for such conjugates intended for in vitro diagnostic kit components defaults to ISO 13485:2016, section 7.3.6 (design verification), supplemented by stability protocols aligned with CLSI EP25-A. After conjugation, the crude mixture passes through an ÄKTA Pure 25 system equipped with a Superdex 200 Increase 10/300 GL column equilibrated in PBS + 0.05% NaN₃; fractions with a fluorophore/protein absorbance ratio (A₄₉₅/A₂₈₀) of 1.8–2.4 are retained. Terminal products are lateral flow cassette test strips for cardiac troponin I or procalcitonin, sold in single-use blister packs within ISO 15223-1:2021-compliant labelling.When a fluorometric signal bleed from the sample pad into the conjugate release matrix cannot be tolerated, substitution of the direct NHS ester protocol with a heterobifunctional spacer—N-succinimidyl 3-(2-pyridyldithio)propionate (SPDP)—followed by controlled fluorescein maleimide coupling becomes the fallback. This modifies the downstream work-up: diafiltration against 20 mM sodium phosphate, 150 mM NaCl, pH 7.2 using tangential flow cassettes with 30 kDa MWCO regenerated cellulose membranes removes low-molecular-weight quenchers before the SPDP activation step. The adoption of this fallback path is triggered when the conjugate release pad—typically fiberglass grade 8964 (Ahlstrom-Munksjö)—shows more than 3% fluorescent species migration on accelerated ageing at 45°C and 75% RH over 14 days. The final reader-interpreted assay cartridges enforce a sample addition volume tolerance of ±2 µL via precision cut capillary channels.How Does the 5-(and 6)-Isomer Ratio Affect Conjugation Homogeneity?The commercial reagent arrives as a mixed isomer preparation—5-carboxyfluorescein NHS ester typically composing 54–62% of the mixture and the 6-isomer the remainder—a ratio verified by reversed-phase HPLC on a C18 column using 0.1% TFA/acetonitrile gradient. For solution-phase protein labelling destined for flow cytometry, this heterogeneity is rarely disqualifying. However, in applications where the conjugate must subsequently be immobilized onto a solid surface via the carboxyl group—such as magnetic bead-based Luminex xMAP® microsphere panels—the 6-isomer reacts preferentially with amine-modified bead surfaces due to steric accessibility, while the 5-isomer forms an internal lactone that is unreactive under aqueous conditions. Conjugation failure rates spike 3- to 4-fold on carboxylated polystyrene beads of 6.5 µm diameter when the total NHS ester input is calculated solely from bead surface area without factoring in the reactive 6-isomer fraction. A pre-conjugation isomer fractionation by preparative C8 column (isocratic 22% acetonitrile in 50 mM triethylammonium acetate) yields the 6-isomer at >94% purity, which is then used at a surface amine-to-NHS ester ratio of 1:20 in dry dimethyl sulfoxide containing 5% v/v triethylamine. The fluorescent bead product must then be qualified by MESF (molecules of equivalent soluble fluorophore) bead standards traceable to NIST SRM 1934. This specification path complies with CLSI H62-A guidelines for flow cytometric quantitative fluorescence measurements.Formamide-Free Hybridisation Buffer Demands on Xanthene Dye Stability During FISH Probe ManufactureFluorescence in situ hybridisation (FISH) probes, whether comprising locus-specific bacterial artificial chromosome clones or single-stranded oligonucleotide pools, demand terminal fluorophore labels that survive 16–18 hours of incubation at 37°C in hybridisation mixtures containing 50% v/v formamide. The 1-{[(3',6'-Dihydroxy-3-Oxo-3H-Spiro[2-Benzofuran-1,9'-Xanthen]-5-Yl)Carbonyl]Oxy}Pyrrolidine-2,5-Dione} NHS ester, when attached to a 5’-aminohexyl-modified oligonucleotide in a postsynthetic labelling protocol, displays a half-life of just 3.2 hours in that formamide content, cleaving the conjugating thiourea linkage and generating free fluorescein that diffuses into the mounting medium. This constraint necessitates a formamide-free hybridisation buffer system—typically 2× saline sodium citrate (SSC) with 10% w/v dextran sulfate and 0.1% w/v polyvinyl alcohol—in which the dye-linker construct remains 92–94% intact after 18 hours. The subsequent wash stringency at 45°C with 0.1× SSC must not exceed 3 × 5 min cycles; prolonged washes strip the short-wavelength fluorophore selectively. The upstream labelling process itself, conducted on Amino-Modifier C6 dT phosphoramidite-modified oligonucleotides, uses an NHS-to-oligonucleotide ratio of 30:1 in 0.1 M sodium tetraborate/pH 9.0 with 40% v/v formamide carrier, followed by desalting on NAP-10 columns and RP-HPLC purification monitoring absorbance at 260 nm and 494 nm. The purified probe concentrate is aliquoted and lyophilised with a protective excipient mix of 5% w/v trehalose and 0.1% w/v bovine serum albumin, which suppresses fluorophore dimerisation during storage at -20°C. Finished FISH probe kits, classified as Class I IVD under FDA 21 CFR 866.5910, must demonstrate hybridisation specificity through Southern blot validation and retain a signal-to-background ratio of >50:1 when tested on cultured amniocyte metaphase spreads.
When Ratiometric Intracellular pH Monitoring Requires NHS-Activated Fluorescein Immobilisation on MicrocarriersMicrosphere-based intracellular pH sensors utilise the pH-dependent emission (λem 515 nm) of fluorescein when measured against a pH-insensitive reference channel. Fabrication of these sensors via covalent attachment of 1-{[(3',6'-Dihydroxy-3-Oxo-3H-Spiro[2-Benzofuran-1,9'-Xanthen]-5-Yl)Carbonyl]Oxy}Pyrrolidine-2,5-Dione} to amino-functionalised 3.0 µm crosslinked poly(methyl methacrylate) microspheres yields a surface coverage of 2.7–3.0 × 10⁵ fluorophores per bead at a feed ratio of 50 µg NHS ester per 1 mg beads in anhydrous DMF with 10 mM triethylamine. The kinetic bottleneck is the dimethylformamide-induced swelling of the PMMA core, which alters the effective surface amine density and introduces irregular fluorescence intensity across bead populations as measured by analytical flow cytometry on a BD LSRFortessa X-20 fitted with a 488 nm laser. Post-conjugation quenching with 100 mM Tris-HCl (pH 8.0) for 1 hour and sonication at 35 kHz for 10 min reduces inter-bead CV to <8%. The referenced pH calibration protocol follows IUPAC Recommendations for pH Measurement in Cells and employs clamped intracellular buffers with 10 µM nigericin in high-K⁺ Ringer solutions. The terminal product—a lyophilised pellet of pH-sensing microcarriers—is sold as a research-use-only consumable within ISO 9001:2015-certified facilities, supplied with a calibration sheet plotting fluorescence ratio (I₅₁₅/I₆₁₀) against pH 5.8–7.8.Low-background no-wash ELISA configurations for interleukin-6 (IL-6) detection in human serum rely on a pre-formed detection antibody-fluorescein complex where unconjugated NHS ester is quenched to extinction by addition of 0.5 M hydroxylamine (pH 7.5) immediately after the 60-minute coupling window. This step is critical because residual reactive NHS groups on the detection antibody can covalently attach to capture antibody during the immunocomplex formation step, generating a bridging signal that elevates background noise above the 0.12 pg/mL calibration blank limit. The coupling itself is performed with 10 µg of 1-{[(3',6'-Dihydroxy-3-Oxo-3H-Spiro[2-Benzofuran-1,9'-Xanthen]-5-Yl)Carbonyl]Oxy}Pyrrolidine-2,5-Dione} per 100 µg of detector monoclonal antibody (molar ratio approximately 14:1) in freshly degassed 0.1 M sodium bicarbonate buffer, pH 8.3, for 60 min at ambient temperature shielded from ambient light. After hydroxylamine quench, the conjugated antibody is purified by tandem desalting and protein G affinity chromatography, then eluted with gentle 0.1 M glycine/pH 2.8 buffer that is immediately neutralised into 1 M Tris/pH 9.1. The purified conjugate is formulated with a stabiliser cocktail containing 0.5% w/v casein enzymatic hydrolysate and 0.01% w/v ProClin™ 300 and held at 2–8°C. The assembled ready-to-use ELISA plate kit complies with EN ISO 18113-1:2011 labelling requirements and provides a validated lower limit of quantification of 0.25 pg/mL. When manufacturers attempt to accelerate this conjugation by raising the NHS ester to antibody ratio above 22:1, the excess hydrophobic fluorophore molecules begin to fold into the immunoglobulin’s hydrophobic pockets, triggering self-quenching and a precipitous drop in quantum yield from 0.93 to 0.34, a reduction documented across multiple humanised IgG1 isotypes. Process Sequence Variability in Automated Oligonucleotide 3’-Fluorescein Labelling on Solid SupportAutomated DNA synthesisers incorporating the NHS ester reagent for on-column 3’-terminal labelling of oligonucleotide therapeutic intermediates—specifically antisense oligonucleotides under ICH Q7A guidance—require the solid support to be amino-functionalised controlled-pore glass with a loading density not exceeding 35 µmol/g to ensure adequate spatial separation. The reagent is dissolved in anhydrous acetonitrile with 0.1 M diisopropylethylamine at a concentration of 50 mg/mL and recirculated through the column for 45 min at 1 mL/min flow rate using a peristaltic pump with a bypass pressure limiter set to 8 bar. Post-synthesis cleavage and deprotection with concentrated aqueous ammonia at 55°C for 8 hours must be meticulously anhydrous in the final wash step because any residual water in the ammonolysis solution attacks the succinimidyl ester before it reaches the 3’-amine, hydrolysing 11–18% of the reagent charge to the unreactive carboxylic acid. The crude oligonucleotide is purified by strong anion-exchange HPLC on a Resource Q 1 mL column with a gradient of 0–0.5 M NaCl in 20 mM NaOH over 30 column volumes. Fractions containing the full-length fluorescein-labelled product are desalted against water for injection using a 1 kDa MWCO dialysis cassette and lyophilised. Quality release specifications include an oligonucleotide purity of ≥92% by analytical C18 HPLC and mass identity confirmed within ±0.5 Da by ESI-MS. The finished drug substance, if intended for preclinical toxicology, is released under GLP regulations per 21 CFR Part 58, addressing potential impurity limits for the 5- and 6-isomer contaminants.
NHS-fluorescein doping of poly(vinyl alcohol)-based hydrogel biosensors for continuous glucose monitoring presents a critical processing window conflict. The hydrogel precursor solution, containing 10% w/v PVA (Mw 146,000–186,000, 99+% hydrolysed), 0.3% w/v sodium tetraborate crosslinker, and the NHS ester dye conjugate in a pre-reacted state, must be drop-cast onto a screen-printed carbon electrode within 90 seconds of NHS addition. Exceeding this pot life results in gelation initiated by trace amine residues on the PVA backbone reacting with the ester, forming intra-hydrogel fluorescent hotspots that distort the sensor’s optical response. The conjugate is prepared offline by reacting 1 mg/mL of the NHS ester with 0.5 mg/mL of a high-molecular-weight polyallylamine backbone (250 kDa) in dry DMSO for 2 hours, dialysing against DMSO, and spiking into the hydrogel mix at 0.05% w/w. The assembled enzyme-based sensor patch is tested for fluorescence drift over 14-day implantation simulation in phosphate-buffered saline at 37°C, with an acceptance criterion of <12% signal loss. Devices are labelled as single-use disposable biosensors in accordance with ISO 15197:2013 criteria for in vitro diagnostic test systems for self-testing, though the specific NHS ester component is considered a raw material addressed in the manufacturer’s MDSAP audit scope rather than product registration. For immunohistochemical (IHC) multiplex assays performed on automated staining platforms such as the Roche Ventana Benchmark Ultra, the direct fluorescein conjugate must withstand a series of heat-induced epitope retrieval steps at 100°C for 32–64 minutes in CC1 retrieval buffer (Tris/borate/EDTA, pH 8.5). Conjugates prepared with 6-isomer-enriched NHS ester (isolated by the preparative procedure described earlier) show superior thermal endurance, retaining 78–82% of initial fluorescence after one hour of boiling exposure compared to 55–61% for the mixed-isomer preparation. The conjugation feed ratio is held at 5:1 molar excess to primary antibody to minimise crosslinking, which would produce insoluble aggregates that precipitate in the instrument’s liquid flow path and trigger pressure alarms above 0.8 bar. Post-conjugation purification with a protein A resin column and elution at pH 3.0 is stringently controlled because prolonged exposure of fluorescein to low pH (<4.0) for more than 10 minutes irreversibly quenches the fluorophore. The finished IHC antibody ready-to-use dispenser is loaded onto the instrument alongside haematoxylin counterstain; the conjugate’s optimal working concentration of 1.25 µg/mL in proprietary antibody diluent is validated through tissue microarray screening and digital image analysis measuring H-score linearity across 0–3+ staining intensity. These reagents fall under IVDR (EU) 2017/746 classification as Class A products, with technical documentation structured per Annex II, section 6.1, substantiating the raw material chemical specification for the NHS ester including isomer distribution, free acid content (<1.5% w/w), and bioburden assessment (<50 CFU/g). |
Competitive 1-{[(3',6'-Dihydroxy-3-Oxo-3H-Spiro[2-Benzofuran-1,9'-Xanthen]-5-Yl)Carbonyl]Oxy}Pyrrolidine-2,5-Dione prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
The compound 1-{[(3',6'-Dihydroxy-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthen]-5-yl)carbonyl]oxy}pyrrolidine-2,5-dione (CAS 92557-80-7) constitutes the 5-carboxyfluorescein (5-FAM) N-hydroxysuccinimide ester, a heterobifunctional xanthene-derived fluorophore bearing a single amine-reactive succinimidyl ester substituent at the 5-position of the pendant benzoic acid. The molecular formula C25H15NO9 corresponds to an anhydrous formula mass of 473.39 g·mol⁻¹. The lyophilized powder, when stored under argon in amber vials at ≤−20 °C, retains ≥95% active ester content for 24 months post-manufacture, as determined by reversed-phase HPLC with UV detection at 254 nm against a certified reference standard. Reconstitution in anhydrous dimethylformamide (DMF, water specification ≤50 ppm) or dimethyl sulfoxide (DMSO, dried over 4 Å molecular sieves) at concentrations of 10–25 mM yields a straw-yellow solution with an absorption maximum of 494 nm (ε = 75 000 M⁻¹·cm⁻¹ in 0.1 M sodium phosphate, pH 9.0). Emission scans collected with a bandpass of 5 nm exhibit λem,max = 518 nm, and the quantum yield—determined relative to disodium fluorescein in 0.1 M NaOH by the Parker‑Rees method (IUPAC Technical Report, Pure Appl. Chem. 2011)—lies at Φ = 0.93 under the same alkaline conditions. This NHS ester is designed exclusively for covalent ligation to primary aliphatic amines on proteins, peptides, amino-modified oligonucleotides, and small-molecule amine spacers under strictly controlled anhydrous post-reconstitution workflows.
The commercial landscape offers both 5- and 6-carboxyfluorescein NHS esters as individual regioisomers, and the distinction bears direct consequences on conjugate homogeneity. In the 5-FAM isomer, the carboxamide linkage formed post‑acylation places the fluorophore dipole vector approximately collinear with the long axis of the xanthene ring system, whereas the 6-FAM isomer orients the dipole into an angular geometry relative to the chromophore plane. For immunoglobulin G (IgG) labeling at molar fluorophore-to-protein ratios (F/P) exceeding 4:1, the 5-FAM conjugate consistently displays a narrower hydrodynamic radius distribution as measured by size-exclusion chromatography coupled to multi-angle light scattering (SEC‑MALS), reducing aggregate fractions to ≤2.3% of total peak area versus 6.1–7.8% for the 6-FAM analog under identical 0.1 M sodium bicarbonate (pH 8.3, 2 h, 22 °C) coupling conditions. This disparity is attributed to reduced inter‑fluorophore stacking propensities; steady‑state anisotropy measurements (r = 0.281 for 5-FAM-IgG at F/P = 3.8 versus r = 0.215 for 6-FAM-IgG at equivalent F/P) confirm lower homo-Förster resonance energy transfer (homo-FRET) self-quenching. Consequently, batch records for immunofluorescence microscopy reagents (primary antibody panels targeting cytokeratin 18, Her2/neu, and CD20) preferentially specify 5-FAM NHS ester when the intended detection channel occupies the 488 nm argon-ion laser line and requires signal linearity across a 3-log antigen concentration range.
The succinimidyl ester group exhibits a hydrolysis half-life (t1/2) that is strongly pH‑ and temperature‑dependent, and the kinetic window defines the permissible aqueous reaction envelope. In 0.1 M sodium phosphate buffer at 4 °C, t1/2 for the 5-FAM NHS ester is 58 ± 4 min at pH 7.4, shortening to 14 ± 2 min at pH 8.3 and to 4.5 ± 0.6 min at pH 9.0. When the incubation temperature is raised to 25 °C, the corresponding t1/2 values contract to 23 min, 6 min, and 1.8 min, respectively, following pseudo-first‑order kinetics confirmed by isosbestic point monitoring at 360 nm. Labelling protocols that demand >30% NHS ester survival at the end of the incubation period therefore stipulate a maximum coupling pH of 8.0 and a maximum temperature of 22 °C when the substrate amine pKa falls below 8.5. For lysine ε‑amines on the surface of bovine serum albumin (BSA), 84% of added NHS ester is consumed within the first 10 min at pH 8.5 and 20 °C, as quantified by fluorescamine back‑titration of residual free amines, after which point the residual active ester pool hydrolyzes competitively. The practical implication is that reactive addition ratios are calibrated not to the initial molar input but to the fraction that survives the conjugation interval, and documentation accompanying each production lot reports lot‑specific hydrolysis rate constants measured at pH 7.4 and 25 °C using a stopped‑flow spectrophotometer (Applied Photophysics SX20) with a 1 ms dead time.
The spectral signature of 5-FAM is sensitive to the protonation state of the phenolic oxygen at the 3′ position (pKa = 6.4) and to the lactone‑open/closed equilibrium of the spirolactone ring. Upon conjugation to a protein, the apparent pKa shifts downward by 0.3–0.5 units owing to the altered local dielectric, and the quantum yield plateaus at Φ = 0.85 only at conjugate environment pH ≥8.5. Flow cytometric calibration with MESF (molecules of equivalent soluble fluorochrome) microspheres reveals that an anti‑CD4‑5-FAM conjugate suspended in phosphate‑buffered saline (PBS, pH 7.2) yields 72% of the mean fluorescence intensity obtained in a pH‑9.0 borate‑buffered mounting medium matched for identical F/P. Therefore, quantitative immunofluorescence on live‑cell surfaces—where the local pericellular pH rarely exceeds 7.0—must incorporate an internal pH‑response correction derived from radiometric measurements of the conjugate at 490/518 nm and 450/518 nm. These radiometric factors are supplied in the certificate of analysis as a ratio of emission intensities recorded at pH 7.0 and pH 9.0 (I7.0/I9.0), which for lot JC‑228‑4 was determined to be 0.69. Operators should note that conjugates stored in Tris‑buffered saline (TBS) at 4 °C for >48 h exhibit a progressive decline in this ratio, consistent with carbinolamine hydrolysis products interfering with the lactone equilibrium.
| Attribute | 5-FAM NHS | 6-FAM NHS | FITC (mixed isomer) |
|---|---|---|---|
| λabs,max (nm) | 494 | 495 | 492 |
| λem,max (nm) | 518 | 519 | 516 |
| ε (M⁻¹·cm⁻¹) at λmax | 75 000 | 76 000 | 73 000 |
| Post-conjugation quantum yield (protein, pH 9.0) | 0.85 | 0.82 | 0.79 |
| Hydrolysis t1/2 at pH 8.3, 25 °C (min) | 6.0 | 5.7 | 4.2 (pH instability) |
| Long-term dry storage stability (−20 °C, months) | 24 | 18 | 12 |
In a typical solid‑phase peptide synthesis (SPPS) labeling strategy where the fluorophore is appended to the N‑terminus of a resin‑bound peptidyl‑resin after Fmoc deprotection, the 5-FAM NHS ester is introduced at a 4‑fold molar excess relative to free amine groups in anhydrous N-methyl‑2‑pyrrolidone (NMP) containing 0.1 M N,N-diisopropylethylamine (DIPEA). Coupling proceeds for 2 h at 25 °C under nitrogen agitation, followed by resin washes with DMF and dichloromethane. Cleavage from Rink amide resin with trifluoroacetic acid/triisopropylsilane/water (95:2.5:2.5) yields the crude 5-FAM-peptide, which upon preparative C18 HPLC purification elutes as a single peak with ≥98% purity at 220 nm and exhibits an intact mass within ±0.5 Da of the theoretical value by ESI‑TOF mass spectrometry. For peptides exceeding 20 residues containing multiple basic side chains, post‑cleavage precipitation in ice‑cold diethyl ether is repeated three times to eliminate residual scavenger carbocations that otherwise form non‑fluorescent adducts with the xanthene ring.
When labeling low‑abundance antibody fragments (Fab′) at concentrations ≤0.5 mg·mL⁻¹, the bimolecular rate constant for amine‑acylation becomes rate‑limiting relative to hydrolysis. Kinetic competition experiments with p-nitrophenyl acetate as a competitive nucleophile indicate a second‑order rate constant of 2.1 × 10³ M⁻¹·s⁻¹ for the reaction between 5-FAM NHS and ε‑amino groups of poly‑L‑lysine (molecular weight 30 kDa) in 0.1 M borate, pH 8.0 at 4 °C. This value drops to 0.8 × 10³ M⁻¹·s⁻¹ when the poly‑L‑lysine concentration falls below 1 µM due to the transition from pseudo‑first‑order to second‑order kinetic regime. As a consequence, coupling to a 0.2 mg·mL⁻¹ Fab′ solution (~4 µM) requires at least a 40‑fold molar excess of NHS ester to achieve an F/P ratio of 2.0, accepting that ~75% of the activated ester will be sacrificed to hydrolysis. The resulting conjugate must be purified by PD‑10 desalting columns (Sephadex G‑25, GE Healthcare) pre‑equilibrated with pH‑7.4 PBS, with the fluorescent fraction eluting in the void volume (1.5–2.0 mL) while hydrolyzed 5‑carboxyfluorescein (5‑FAM free acid) is retained and elutes at 3.5–5.0 mL. Residual free dye content is verified by TSKgel G3000SWXL size‑exclusion HPLC (Tosoh Bioscience) with fluorescence detection (ex 494 nm, em 518 nm) and must register ≤0.5% of total peak area before the conjugate is deemed acceptable for single‑molecule fluorescence coincidence experiments requiring background photon counts of ≤3 kHz.
5-FAM NHS ester is irreversibly inactivated by nucleophilic buffer components. Solutions must be prepared free of Tris, glycine, ammonium salts, or primary amine‑containing stabilizers such as BSA, gelatin, or ethanolamine. If a protein is supplied in a Tris‑HCl storage buffer (50 mM Tris, 150 mM NaCl, pH 7.5), buffer exchange into 0.1 M sodium bicarbonate pH 8.3 using a Zeba Spin Desalting Column (7K MWCO, Thermo Scientific) is required prior to NHS ester addition. The presence of sodium azide (NaN3) as an antimicrobial at concentrations of ≤3 mM does not interfere with acylation; however, azide concentrations ≥10 mM produce a detectable shoulder in the HPLC trace at 254 nm due to acetyl‑azide transfer product (confirmed by LC‑MS with an observed [M+H]+ shift of +42 Da). Dithiothreitol (DTT) and 2‑mercaptoethanol must be removed to ≤0.1 mM because thiols attack the succinimidyl carbonyl with a rate constant comparable to amines (k2 ~ 1.5 × 10³ M⁻¹·s⁻¹), yielding a non‑fluorescent thioester that undergoes rapid intramolecular S→N acyl shift in the presence of adjacent nucleophiles. EDTA at 5 mM is tolerated and recommended for metalloprotease inhibition, as it does not react with the NHS ester under the typical pH window.
| Solvent | Water content (ppm) | Remaining active ester (%) | Remarks |
|---|---|---|---|
| Anhydrous DMF (sure‑seal) | ≤30 | 97 | Recommended; store over sieves |
| Anhydrous DMSO | ≤50 | 94 | Freeze‑thaw stable 5 cycles |
| Anhydrous NMP | ≤40 | 92 | Higher viscosity limits pipetting accuracy |
| Acetonitrile (HPLC grade) | ~100 | 78 | Partial hydrolysis after 1 h |
| Dioxane (anhydrous) | ≤30 | 95 | Peroxide‑free grade mandatory |
| DMSO + 5% water (v/v) | — | 43 | Not suitable for stock storage |
For oligonucleotide 5′-aminohexyl linkers synthesized on a 1 µmol controlled‑pore glass (CPG) column, the 5-FAM NHS ester is dissolved in anhydrous DMSO to 0.2 M and 25 µL of this solution is mixed with the oligo in 200 µL of freshly prepared 0.1 M sodium carbonate‑bicarbonate buffer, pH 9.0. The coupling vessel is rotated end‑over‑end at room temperature in darkness for 4 h, after which unreacted dye is removed by size‑exclusion NAP‑5 column chromatography (Sephadex G‑25). The resulting 5-FAM‑labeled oligonucleotide is analyzed by reverse‑phase ion‑pair HPLC using a 5 µm C18 column (4.6 × 250 mm) with a triethylammonium acetate‑acetonitrile gradient; the labeled product elutes 2–3 min later than the unlabeled oligonucleotide. The product peak area must constitute ≥90% of total absorbance at 260 nm, and the molar absorptivity ratio A260/A494 is used to compute labeling efficiency, which for a 21‑mer phosphorothioate oligonucleotide typically falls in the range of 1.8–2.2 dye per molecule. Conjugates are desalted, dried in a vacuum centrifuge, and stored at −20 °C in single‑use aliquots to avoid freeze‑thaw mediated duplex dissociation.
In the specific context of fluorescence in situ hybridization (FISH) probe preparation, the 5-FAM NHS ester has been incorporated into nick‑translated DNA probes targeting centromeric repetitive sequences of chromosome 12p11.1‑q11. After nick translation with DNA polymerase I and DNase I in the presence of aminoallyl‑dUTP (aa‑dUTP) at a molar ratio of aa‑dUTP:dTTP of 1:4, the purified DNA is coupled overnight with a 30‑fold molar excess of 5-FAM NHS ester in 0.1 M sodium bicarbonate pH 8.5. Unincorporated dye is removed with a Micro Bio‑Spin P‑30 column (Bio‑Rad), and the probe is resuspended in hybridization buffer containing 50% formamide, 2× SSC, and 10% dextran sulfate. The probe yields a signal‑to‑noise ratio of 18:1 on metaphase chromosome spreads when imaged with a 100× oil‑immersion objective (NA 1.4), a FITC‑optimized filter cube (ex 470/40, em 525/50), and a cooled CCD camera integrating for 500 ms.
When substituting 5-FAM NHS ester for the isothiocyanate analog (FITC) in high‑throughput microarray antibody spotting, the reduced tendency of the NHS‑derived carboxamide linkage to undergo photo‑oxidative cleavage translates into a 2.3‑fold longer shelf life for functionalized glass slides under ambient room‑light exposure and 60% relative humidity, as assessed by residual fluorescence intensity after 3 months of storage. The carbamothioate linkage formed by FITC exhibits an oxidation half‑time of 18 days under these conditions, compared to 42 days for the carboxamide, and the fraction of non‑specific binding to the nitrocellulose‑coated slide background remains ≤1.2% for both chemistries. This differential stability is a direct consequence of the higher bond dissociation energy of the amide C–N bond (~305 kJ·mol⁻¹) relative to the thiocarbamoyl C–S bond (~260 kJ·mol⁻¹). Thus, for longitudinal stability studies of cytokine capture antibody arrays (IL‑2, IL‑6, TNF‑α, IFN‑γ) measured on a confocal microarray scanner (ex 488 nm, em 525 nm), the 5-FAM NHS conjugate is preferred when inter‑slide variance must remain below 5% CV over the study window.
The operational boundary for 5-FAM NHS ester in polymer‑supported solid‑state chemical biology includes its incorporation into poly(ethylene glycol) (PEG) hydrogels functionalized with amine‑terminated pendant groups. When a 4‑arm PEG‑amine macromer (molecular weight 10 kDa) is partially functionalized by dropwise addition of 5-FAM NHS in DMF to a 2% (w/v) macromer solution in 0.1 M sodium phosphate pH 8.0 at a dye:amine stoichiometry of 1:20, the resulting gel exhibits a homogeneous fluorescence distribution by confocal z‑stack analysis, with a coefficient of variation in pixel intensity across a 200 µm depth of 4.8%. In contrast, FITC‑labeled hydrogels exhibit 11.3% CV, attributed to FITC aggregation during photopolymerization. Published data for this specific gel‑label configuration at larger scales (> 5 mL gel volume) remains limited, and observed batch‑to‑batch variability in labeling degree (F/P = 0.8–1.2) necessitates normalization of rheological storage moduli (G′) to the measured fluorescence.